Approval · Notice of Compliance 2355 · 2001
ZADITOR: Notice of Compliance 2355
Issued February 16, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2355
- Date
- February 16, 2001
- Company
- Novartis Ophthalmics Novartis Pharmaceuticals (Canada) IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiallergy agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZADITOR | 02242324 | Marketed |
Medicinal ingredients
- KETOTIFEN FUMARATE 0.25 MG per ML